These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 16996113

  • 1. Treatment with paclitaxel plus carboplatin, alone or with irradiation, of advanced or recurrent endometrial carcinoma.
    Arimoto T, Nakagawa S, Yasugi T, Yoshikawa H, Kawana K, Yano T, Taketani Y.
    Gynecol Oncol; 2007 Jan; 104(1):32-5. PubMed ID: 16996113
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of paclitaxel and carboplatin in patients with endometrial cancer].
    Nakamura T, Onishi Y, Yamamoto F, Kouno S, Maeda Y, Hatae M.
    Gan To Kagaku Ryoho; 2000 Feb; 27(2):257-62. PubMed ID: 10700897
    [Abstract] [Full Text] [Related]

  • 3. Carboplatin and paclitaxel in advanced or metastatic endometrial cancer.
    Pectasides D, Xiros N, Papaxoinis G, Pectasides E, Sykiotis C, Koumarianou A, Psyrri A, Gaglia A, Kassanos D, Gouveris P, Panayiotidis J, Fountzilas G, Economopoulos T.
    Gynecol Oncol; 2008 May; 109(2):250-4. PubMed ID: 18299146
    [Abstract] [Full Text] [Related]

  • 4. Paclitaxel, epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: a Hellenic Co-operative Oncology Group (HeCOG) study.
    Papadimitriou CA, Bafaloukos D, Bozas G, Kalofonos H, Kosmidis P, Aravantinos G, Fountzilas G, Dimopoulos MA, Hellenic Co-operative Oncology Group.
    Gynecol Oncol; 2008 Jul; 110(1):87-92. PubMed ID: 18455782
    [Abstract] [Full Text] [Related]

  • 5. A phase I study of ifosfamide, paclitaxel, and carboplatin in advanced and recurrent cervical cancer.
    Downs LS, Judson PL, Argenta PA, Carson LF, Boente MP.
    Gynecol Oncol; 2004 Nov; 95(2):347-51. PubMed ID: 15491756
    [Abstract] [Full Text] [Related]

  • 6. A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer.
    Duska LR, Berkowitz R, Matulonis U, Muto M, Goodman A, McIntyre JF, Klein A, Atkinson T, Seiden MV, Campos S.
    Gynecol Oncol; 2005 Jan; 96(1):198-203. PubMed ID: 15589601
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: a phase II study of the Southwest Oncology Group.
    Scudder SA, Liu PY, Wilczynski SP, Smith HO, Jiang C, Hallum AV, Smith GB, Hannigan EV, Markman M, Alberts DS, Southwest Oncology Group.
    Gynecol Oncol; 2005 Mar; 96(3):610-5. PubMed ID: 15721401
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combination chemotherapy with carboplatin, paclitaxel and pegylated liposomal doxorubicin for advanced or recurrent carcinosarcoma of the uterus: clinical experience of a single institution.
    Pectasides D, Pectasides E, Papaxoinis G, Xiros N, Sykiotis C, Papachristodoulou A, Tountas N, Panayiotides J, Economopoulos T.
    Gynecol Oncol; 2008 Sep; 110(3):299-303. PubMed ID: 18602677
    [Abstract] [Full Text] [Related]

  • 14. Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer.
    Lupe K, D'Souza DP, Kwon JS, Radwan JS, Harle IA, Hammond JA, Carey MS.
    Gynecol Oncol; 2009 Jul; 114(1):94-8. PubMed ID: 19406459
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC).
    Cohen RB, Langer CJ, Simon GR, Eisenberg PD, Hainsworth JD, Madajewicz S, Cosgriff TM, Pierce K, Xu H, Liau K, Healey D.
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):81-9. PubMed ID: 17031646
    [Abstract] [Full Text] [Related]

  • 17. A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group.
    Pignata S, Scambia G, Pisano C, Breda E, Di Maio M, Greggi S, Ferrandina G, Lorusso D, Zagonel V, Febbraro A, Riva N, De Rosa V, Gallo C, Perrone F, Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies Group.
    Br J Cancer; 2007 Jun 04; 96(11):1639-43. PubMed ID: 17486128
    [Abstract] [Full Text] [Related]

  • 18. Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience.
    Tinker AV, Bhagat K, Swenerton KD, Hoskins PJ.
    Gynecol Oncol; 2005 Jul 04; 98(1):54-8. PubMed ID: 15904950
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Placental leucine aminopeptidase (P-LAP) expression is associated with chemosensitivity in human endometrial carcinoma.
    Shibata K, Kikkawa F, Kondo C, Mizokami Y, Kajiyama H, Ino K, Nomura S, Mizutani S.
    Gynecol Oncol; 2004 Nov 04; 95(2):307-13. PubMed ID: 15491750
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.